Patent · US Active

Albumin variants

US10934341B2 · kind B2 · utility

2Cited by
87References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 10, 2019
Grant dateMar 2, 2021
Priority date
Expiry dateOct 10, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.